Raphael Pharmaceutical Inc (RAPH)
1.00
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Raphael Pharmaceutical Cash from Financing (TTM): 1.145M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.145M |
| September 30, 2023 | 1.598M |
| June 30, 2023 | 1.021M |
| March 31, 2023 | 1.035M |
| December 31, 2022 | 0.896M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.243M |
| June 30, 2022 | 1.231M |
| March 31, 2022 | 1.442M |
| December 31, 2021 | 1.476M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.896M
Minimum
Dec 2022
1.598M
Maximum
Sep 2023
1.232M
Average
1.231M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
| InspireMD Inc | 37.53M |
| Pluri Inc | -- |
| BiomX Inc | 2.899M |
| Alpha Tau Medical Ltd | -- |
| Holdco Nuvo Group DG Ltd | 14.44M |